Zimmer Biomet Hits Day Low of $83.72 Amid Price Pressure

Zimmer Biomet Holdings, Inc. experienced a notable decline today, with the stock dropping by 5.64% as of June 30, 2026. The stock reached an intraday low of USD 83.72, reflecting ongoing challenges in its market performance. Over the past week, Zimmer Biomet has seen a decrease of 1.69%, contrasting with a 1.82% gain in the S&P 500. In terms of longer-term performance, the stock has faced significant headwinds, with a 40.87% decline over the past three years and a 44.82% drop over the last five years. Year-to-date, Zimmer Biomet is down 4.26%, while the S&P 500 has gained 9.55%. Financial metrics indicate a mixed picture; the company has reported a net profit of USD 753.55 million for the first nine months, reflecting a decline of 28.26%. The interest coverage ratio stands at 869.79, and the debt-equity ratio is at a high of 56.01%. Despite these challenges, the stock offers a dividend yield of 19.45%, and its price-to-earnings ratio is 28.00. Overall, Zimmer Biomet's performance continues to lag behind the broader market, highlighting the need for strategic reassessment.